[Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency] (Q79440800)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

[Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

alpha-1-antitrypsin deficiency

23 December 2019

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

4

Rosend Jardí

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Rafael Vidal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Ignacio Blanco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Marc Miravitlles

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Committee on the National Registry of Individuals with Alpha-1 Antitrypsin Deficiency

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

Archivos de Bronconeumologia

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

645-659

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Alpha1-antitrypsin: not just an antiprotease: extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

alpha1-Antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Liver Disease in Alpha1-Antitrypsin Deficiency Detected by Screening of 200,000 Infants

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Alpha 1-antitrypsin: more than just deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Influence of deficient α1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Emphysema of early onset associated with a complete deficiency of alpha-1-antitrypsin (null homozygotes)

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Alpha-1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Lung function in adolescents with alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ).

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ)

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Smoking, lung function, and alpha 1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Predictors of mortality in alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Body mass index and mortality in patients with severe alpha 1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

[The current state of substitution treatment in congenital emphysema due to alpha-1-antitrypsin deficiency. The report of the National Registry]

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Alpha1-antitrypsin Pi phenotypes S and Z in Spain: an analysis of the published surveys

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Susceptibility genes for rapid decline of lung function in the lung health study

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Genetic risk factors for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

The protease inhibitor PI*S allele and COPD: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

PI SZ phenotype in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

[Evaluation of replacement therapy in emphysema caused by alpha 1-antitrypsin deficiency]

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Clinical features and natural history of severe alpha 1-antitrypsin deficiency. Roger S. Mitchell Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Enfisema por déficit de alfa-1-antitripsina: ¿es realmente una enfermedad infrecuente?

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

The relationship of chronic sputum expectoration to physiologic, radiologic, and health status characteristics in alpha(1)-antitrypsin deficiency (PiZ).

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ)

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Emphysema due to alpha-antitrypsin deficiency: familial study of the YBARCELONA variant.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Results of a case-detection programme for alpha1-antitrypsin deficiency in COPD patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Characterization of the New Alpha-1-Antitrypsin-Deficient PI M-Type Allele, PI M vall d’hebron (Pro 369 →Ser)

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Rapid screening for alpha1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

[Usefulness of the quantification of the alpha-1 serous protein band in the screening of alpha-1-antitrypsin deficiency]

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Programa de cribado para el déficit de α1-antitripsina en pacientes con EPOC mediante el uso de gota de sangre en papel secante

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Simple method for α1-antitrypsin deficiency screening by use of dried blood spot specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

[A report on the Spanish Registry of Patients with Alpha 1-Antitrypsin Deficiency. The Alpha 1-Antitrypsin Deficiency Study Group]

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Alpha1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

[Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease]

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

[New treatments for chronic obstructive pulmonary disease].

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Specific Antibody Response Against the 23-Valent Pneumococcal Vaccine in Patients With α1-Antitrypsin Deficiency With and Without Bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Usefulness of a national registry of alpha-1-antitrypsin deficiency. The Spanish experience

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Two-year results after lung volume reduction surgery in alpha1-antitrypsin deficiency versus smoker's emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency--three-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2807%2960007-X

7 January 2021

10.1016/S1579-2129(07)60007-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17178069%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference